MyGlo Instrument now $4950. Use code GETMYGLO at checkout to get 10% off MyGlo. Shop Now ›

Selectively targeting proteins for removal from the cell, instead of inhibiting protein activity, is a newer modality for potential therapy. The protein is targeted for degradation using the cell’s natural ubiquitin proteasome system (UPS). Compounds such as molecular glues and proteolysis targeting chimeras (PROTACs) initiate this process by linking the target protein to an E3 ligase. The cell’s UPS does the rest.

Promega offers a comprehensive selection of CRISPR-edited cell line pools and clones to facilitate studying popular protein degradation targets, using sensitive bioluminescence technology.

View Available Cell LinesDownload List (PDF)

Need help with assay development, compound screening or profiling? Learn more about our targeted protein degradation services.

View TPD Services
tpd-symposium2023

Learn how Promega collaborates with researchers to develop new tools in a two-day Targeted Protein Degradation Symposium.
Read blog »

Key Questions To Consider When Developing Protein Degraders

Promega offers a portfolio of cell-based assays for use in development of effective protein degraders. These products are used to answer the following key questions:

key stages in protac mediation

Need help with Assay Development, Screening or Profiling?

Learn more about our targeted protein degradation services.